SCHEMBL22911124

SCHEMBL22911124

O=C(c1ccc2cc(Br)ccc2c1)N1CC2C(C1)[C@@H]1CN(C(=O)c3ccc4[nH]nnc4c3)C[C@H]21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ GPR183 P32249 2/20 0.37
▸ HRH4 Q9H3N8 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ TLR2 O60603 1/20 0.36
▸ TLR1 Q15399 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ L3MBTL3 Q96JM7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16759933 1.00 MEN1 (0.42) MEN1POLBKMT2AGPR183HRH4
SCHEMBL16759836 0.89 NPC1 (0.46) MEN1POLBKMT2ATLR2TLR1
SCHEMBL22911062 0.89 NPC1 (0.46) MEN1POLBKMT2ATLR2TLR1
SCHEMBL16759923 0.87 NPC1 (0.38) HRH4TLR2TLR1KDM2B
SCHEMBL22911001 0.87 NPC1 (0.38) HRH4TLR2TLR1KDM2B
SCHEMBL16759839 0.87 ENPP2 (0.46) KMT2AGPR183HRH4HRH3
SCHEMBL22910992 0.85 CHRNB2 (0.44) HRH4HRH3KDM2B
SCHEMBL16759897 0.85 CHRNB2 (0.44) HRH4HRH3KDM2B
SCHEMBL22911142 0.84 HTR2B (0.47) TLR2TLR1
SCHEMBL22911045 0.84 ALDH1A1 (0.40) KDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2021-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL NPY1R, NPY2R, DECR1 MEN1 902/4885POLB 482/4885KMT2A 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback